SPRY2 and B-cell non-Hodgkin lymphoma: In agreement, epigenetic silencing and repressed expression of Spry2 in mouse and human mature B-cell tumor cell lines and a T-cell leukemia 1-transgenic (TCL1-tg) mouse model of B-cell lymphoma as well as in human B-cell lymphoma samples were reported by Frank et al. [67].